Join Us at ACOG 2024
Are you attending ACOG 2024? Join us at booth 927 to learn more about the women’s health solutions BD provides to you and your peers.
We have a passion for improving and advancing the world of women's health. And we believe in innovative medical technology and the potential of the future.
Products and topics of discussions will include:
- BD Onclarity™ HPV Assay
- BD Vaginal Panel
- BD CTGCTV2 Assay
Meet us at the BD sponsored lunch symposium
Making sense of it all: Advancements in cervical cancer screening using
BD Onclarity™ HPV Assay with extended genotyping
Friday May 17th 11:45 a.m.-12:30 p.m. in the lunch symposium, room 154
Speakers:
 |
 |
 |
|
Cheruba Prabakar, |
Shieva Ghofrany, |
Karen Tang, |
In this presentation, we’ll explore HPV extended genotyping with BD Onclarity™ HPV Assay, which optimizes risk stratification and HPV persistence tracking. Discover how this innovation is reshaping screening and management strategies to bring value to clinical decision-making and patient care. Come learn from these experts who utilize extended genotyping and how it has positively impacted their clinical practice.
Stop by our booth, #927, for our in-booth presentations series
Presentations occur every 30 minutes during the exhibit hours.
These presentations will focus on:
- Real-world data using BD Onclarity™ HPV Assay -- the impact of the HPV vaccine and how this can impact screening strategies.
- BD Onclarity™ HPV Assay and the clinical value of extended genotyping for cervical cancer screening
- BD Vaginal Panel and the clinical value of molecular diagnostic testing for vaginitis to improve patient outcomes
- The value of screening for the 3 most prevalent non-viral STIs in a single test with BD CTGCTV2 Assay
Presented by:
Phil Stephenson, DO, pathologist, BD Onclarity™ HPV Assay user
Shieva Ghofrany, MD, FACOG, OB/GYN
Cheruba Prabakar, MD, FACOG, OB/GYN, BD Onclarity™ HPV Assay user
Karen Tang, MD, MPH, OB/GYN
